Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPOX | P50336 | 13/20 | 0.49 |
| ▸ | MEN1 | O00255 | 3/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.49 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.49 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxadiazon SCHEMBL7577663 | 0.89 | PPOX (0.64) | PPOXMEN1KMT2ATDP1NR1I2 | |
| Diclofop-Methyl SCHEMBL7579808 | 0.89 | PPOX (0.39) | PPOXMEN1KMT2ATDP1NR1I2 | |
| Fenoxaprop SCHEMBL7575581 | 0.82 | PPOX (0.46) | PPOXMEN1KMT2ATDP1NR1I2 | |
| Quizalofop SCHEMBL7581424 | 0.82 | PPOX (0.45) | PPOXMEN1KMT2ATDP1NR1I2 | |
| Mecoprop SCHEMBL7577923 | 0.82 | PPOX (0.53) | PPOXMEN1KMT2ATDP1NR1I2 | |
| Bifenox SCHEMBL7577142 | 0.82 | TDP1 (0.55) | PPOXMEN1KMT2ATDP1NR1I2 | |
| SCHEMBL7582255 | 0.81 | PPOX (0.46) | PPOXMEN1KMT2ATDP1NR1I2 | |
| Clodinafop SCHEMBL7585626 | 0.81 | PPOX (0.47) | PPOXMEN1KMT2ATDP1NR1I2 | |
| Diclofop-Methyl SCHEMBL7577209 | 0.80 | DHODH (0.44) | — | |
| Oxadiazon SCHEMBL7579149 | 0.80 | PPOX (0.48) | PPOXMEN1KMT2ATDP1NR1I2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020004457-A1 | Herbicidal composition | SYNGENTA PARTICIPATIONS AG (CH) | 2002-01-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020004457-A1 | Herbicidal composition | PPOX, ALAD, DDT | PPOX 1/4885MEN1 4274/4885KMT2A 2099/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.